The analysis revealed that ZNF300 was associated with poor OS of NSCLC patients when ZNF300 expression was stratified into three levels of <0.00, 0‐0.25 and >0.25 (Figure S4D). This evidence concerns the gene ZNF300 and non-small cell lung carcinoma.